跳转至内容

MBD0021

Inactivated Bacillus subtilis

Suitable for PCR, sequencing and NGS, >10^8 bacteria/ml

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

NACRES:
NA.24
UNSPSC Code:
43211915
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

form

powder

concentration

>10^8 bacteria/ml

technique(s)

DNA extraction: suitable, DNA sequencing: suitable, PCR: suitable

shipped in

dry ice

storage temp.

−20°C

General description

Standardization of sample analysis is currently needed in microbiome genomics research workflow. Lack of standardization can lead to biases and errors in common processes during sample preparation and analysis such as sample amplification, sequencing and bioinformatics analyses.1 Inactivated Bacillus subtilis (B. subtilis) can serve as standard for benchmarking the performance along the workflow of microbiomics or meta-genomics analyses and as a tool to increase reproducibility and allow comparison of results obtained by different labs.B. subtilis is a gram positive, aerobic bacterium, rod-shaped, endospore-forming, catalase-positive. It is traditionally considered as a soil microorganism.2 Bacillus subtilis is genetically well characterized and serves as a model organism for important gram-positive pathogens such as Bacillus anthracis, Staphylococcus aureus etc.3 B. subtilis possess an extreme adaptation ability to various environmental stress conditions by modifying its motility 4, uptake of exogenous DNA 5, biofilm formation and sporulation6.Recent studies have identified and characterized B. subtilis isolates from human gastrointestinal track suggesting B.subtilis as a gut commensal.7 Moreover, B. subtilis presence in the gut was found to correlate with probiotic effects such as anti-diarrhea effect, anti-microbial effect, immune-stimulatory effect, competition with pathogens, normal flora growth stimulation and prevention of intestinal inflammation.8,9. B. subtilis beneficial effect on gut inflammation may also suggest it as potential probiotic treatment for inflammatory bowel diseases (IBD), including Crohn’s and ulcerative colitis.10 In addition, it was demonstrated that a peptide produced by B. subtilis possess antiviral effect against influenza virus.11

Read here how to use our standards to ensure data integrity for your microbiome research.

Application

Inactivated bacteria are provided at >10^8 bacteria/vial as lyophilized powder. It is recommended to avoid freeze thaw cycles of this product.

Preparation Note

It is recommended to dissolve the lyophilized inactivated bacteria in water (Sigma Cat# W4502 ) supplemented with at least 10% glycerol (Sigma Cat# G5516). Once dissolved it is recommended to aliquot immediately and store at -20°C for up to 1 month and avoid freeze thaw cycles.


存储类别

11 - Combustible Solids

wgk

WGK 3



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库